Watson, C., Knockenhauer, H., Berchuck, A., Davidson, B., Havrilesky, L., Lee, P., … Previs, R. (2022). Prospective, randomized trial of streamlined genetic education and testing for patients with high grade epithelial ovarian, fallopian and peritoneal cancer. In Gynecologic Oncology (Vol. 166, pp. S28–S28).

Watson, Catherine, Hope Knockenhauer, Andrew Berchuck, Brittany Davidson, Laura Havrilesky, Paula Lee, Leah McNally, et al. “Prospective, randomized trial of streamlined genetic education and testing for patients with high grade epithelial ovarian, fallopian and peritoneal cancer.” In Gynecologic Oncology, 166:S28–S28, 2022.

Watson C, Knockenhauer H, Berchuck A, Davidson B, Havrilesky L, Lee P, et al. Prospective, randomized trial of streamlined genetic education and testing for patients with high grade epithelial ovarian, fallopian and peritoneal cancer. In: Gynecologic Oncology. 2022. p. S28–S28.

Watson, Catherine, et al. “Prospective, randomized trial of streamlined genetic education and testing for patients with high grade epithelial ovarian, fallopian and peritoneal cancer.” Gynecologic Oncology, vol. 166, 2022, pp. S28–S28.

Watson C, Knockenhauer H, Berchuck A, Davidson B, Havrilesky L, Lee P, McNally L, Moss H, Secord AA, Menendez C, Kauff N, Iglesias D, Previs R. Prospective, randomized trial of streamlined genetic education and testing for patients with high grade epithelial ovarian, fallopian and peritoneal cancer. Gynecologic Oncology. 2022. p. S28–S28.